Nike trades at 28x forward earnings despite revenue expected to decline 2-4% in Q4, with structural issues in China and EMEA. Earnings next week create a catalyst; a revenue miss below $10.6B would break management’s North America strength thesis, justifying a lower multiple. Shorting NKE ahead of earnings exploits overvaluation and downside risk from continued fundamental weakness. A strong North America quarter or positive forward guidance could trigger a short squeeze; management may successfully execute the cleanup thesis over time.
Nike trades at 28x forward earnings despite revenue expected to decline 2-4% in Q4, with structural issues in China and EMEA. Earnings next week create a catalyst; a revenue miss below $10.6B would break management’s North America strength thesis, justifying a lower multiple. Shorting NKE ahead of earnings exploits overvaluation and downside risk from continued fundamental weakness. A strong North America quarter or positive forward guidance could trigger a short squeeze; management may successfully execute the cleanup thesis over time.
Microsoft's AI revenue is accelerating (123% ARR growth), Copilot seats surging (250% YoY), and Azure expansion is on track; the stock trades at multi-year low forward PE. A strong Q4 earnings report (Azure acceleration, Copilot momentum, FCF recovery signs) would flip the narrative from CapEx overhang to moat, triggering a multiple re-rating. The risk/reward is skewed to the upside as the bear case is already discounted, making a long position attractive ahead of the Q4 release. Q4 earnings disappoint on Azure growth or FCF; CapEx continues to compress margins; macro slowdown impacts enterprise spending. No other actionable trade ideas in this post.
Microsoft's AI revenue is accelerating (123% ARR growth), Copilot seats surging (250% YoY), and Azure expansion is on track; the stock trades at multi-year low forward PE. A strong Q4 earnings report (Azure acceleration, Copilot momentum, FCF recovery signs) would flip the narrative from CapEx overhang to moat, triggering a multiple re-rating. The risk/reward is skewed to the upside as the bear case is already discounted, making a long position attractive ahead of the Q4 release. Q4 earnings disappoint on Azure growth or FCF; CapEx continues to compress margins; macro slowdown impacts enterprise spending. No other actionable trade ideas in this post.
Adobe stock is at 2018 levels, yet AI-first ARR is already above $500M and growing 3x year-over-year; Creative Agent is embedded in ChatGPT and Claude. If the market is mispricing Adobe’s AI monetization potential and freemium risk is overstated, a re-rating could occur as Q3 metrics confirm the bet is paying off. Buying ADBE at current depressed multiples offers a favorable risk/reward, with a catalyst in the next quarter’s MAU and Firefly ARR data. If Q3 MAU growth stalls or Firefly ARR disappoints, the step-down may reveal structural weakness, invalidating the thesis.
Adobe stock is at 2018 levels, yet AI-first ARR is already above $500M and growing 3x year-over-year; Creative Agent is embedded in ChatGPT and Claude. If the market is mispricing Adobe’s AI monetization potential and freemium risk is overstated, a re-rating could occur as Q3 metrics confirm the bet is paying off. Buying ADBE at current depressed multiples offers a favorable risk/reward, with a catalyst in the next quarter’s MAU and Firefly ARR data. If Q3 MAU growth stalls or Firefly ARR disappoints, the step-down may reveal structural weakness, invalidating the thesis.